Which treatment is given to a patient with pheochromocytoma to control high bp before surgery?

1

Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young Jr WF & Endocrine Society. Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2014 99 1915–1942. (https://doi.org/10.1210/jc.2014-1498)

LendersJWDuhQYEisenhoferGGimenez-RoqueploAPGrebeSKMuradMHNaruseMPacakKYoungJr WF & Endocrine Society. Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism2014991915–1942. (https://doi.org/10.1210/jc.2014-1498))| false

• Search Google Scholar
• Export Citation

2

Luiz HV, Tanchee MJ, Pavlatou MG, Yu R, Nambuba J, Wolf K, Prodanov T, Wesley R, Adams K & Fojo T et al.Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study. Clinical Endocrinology 2016 85 62–69. (https://doi.org/10.1111/cen.13066)

LuizHVTancheeMJPavlatouMGYuRNambubaJWolfKProdanovTWesleyRAdamsKFojoTAre patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study. Clinical Endocrinology20168562–69. (https://doi.org/10.1111/cen.13066))| false

• Search Google Scholar
• Export Citation

3

Sibal L, Jovanovic A, Agarwal SC, Peaston RT, James RA, Lennard TW, Bliss R, Batchelor A, Perros P. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clinical Endocrinology 2006 65 186–190. (https://doi.org/10.1111/j.1365-2265.2006.02571.x)

SibalLJovanovicAAgarwalSCPeastonRTJamesRALennardTWBlissRBatchelorAPerrosP. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clinical Endocrinology200665186–190. (https://doi.org/10.1111/j.1365-2265.2006.02571.x))| false

• Search Google Scholar
• Export Citation

4

Pacak K Preoperative management of the pheochromocytoma patient. Journal of Clinical Endocrinology and Metabolism 2007 92 4069–4079. (https://doi.org/10.1210/jc.2007-1720)

PacakKPreoperative management of the pheochromocytoma patient. Journal of Clinical Endocrinology and Metabolism2007924069–4079. (https://doi.org/10.1210/jc.2007-1720))| false

• Search Google Scholar
• Export Citation

5

Grimson KS, Longino FH. Treatment of a patient with a pheochromocytoma; use of an adrenolytic drug before and during operation. Journal of the American Medical Association 1949 140 1273. (https://doi.org/10.1001/jama.1949.82900510003006a)

GrimsonKSLonginoFH. Treatment of a patient with a pheochromocytoma; use of an adrenolytic drug before and during operation. Journal of the American Medical Association1949140 1273. (https://doi.org/10.1001/jama.1949.82900510003006a))| false

• Search Google Scholar
• Export Citation

6

Goldstein RE, O’Neill Jr JA, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW 3rd, Oates JA, Brown N, Nadeau J, Smith B & Page DL et al.Clinical experience over 48 years with pheochromocytoma. Annals of Surgery 1999 229 755–764; discussion 64–66. (https://doi.org/10.1097/00000658-199906000-00001)

GoldsteinREO’NeillJr JAHolcombGW3rdMorganWM3rdNeblettWW3rdOatesJABrownNNadeauJSmithBPageDLClinical experience over 48 years with pheochromocytoma. Annals of Surgery1999229755–764; discussion 64–66. (https://doi.org/10.1097/00000658-199906000-00001))| false

• Search Google Scholar
• Export Citation

7

Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T & Mannelli M et al.Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension 2020 38 1443–1456. (https://doi.org/10.1097/HJH.0000000000002438)

LendersJWMKerstensMNAmarLPrejbiszARobledoMTaiebDPacakKCronaJZelinkaTMannelliMGenetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension2020381443–1456. (https://doi.org/10.1097/HJH.0000000000002438))| false

• Search Google Scholar
• Export Citation

8

Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K & North American Neuroendocrine Tumor Society (NANETS ). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 2010 39 775–783. (https://doi.org/10.1097/MPA.0b013e3181ebb4f0)

ChenHSippelRSO’DorisioMSVinikAILloydRVPacakK & North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas201039775–783. (https://doi.org/10.1097/MPA.0b013e3181ebb4f0))| false

• Search Google Scholar
• Export Citation

9

Groeben H, Walz MK, Nottebaum BJ, Alesina PF, Greenwald A, Schumann R, Hollmann MW, Schwarte L, Behrends M & Rossel T et al.International multicentre review of perioperative management and outcome for catecholamine-producing tumours. British Journal of Surgery 2020 107 e170–e178. (https://doi.org/10.1002/bjs.11378)

GroebenHWalzMKNottebaumBJAlesinaPFGreenwaldASchumannRHollmannMWSchwarteLBehrendsMRosselTInternational multicentre review of perioperative management and outcome for catecholamine-producing tumours. British Journal of Surgery2020107e170–e178. (https://doi.org/10.1002/bjs.11378))| false

• Search Google Scholar
• Export Citation

10

Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. Journal of Clinical Endocrinology and Metabolism 2001 86 1480–1486. (https://doi.org/10.1210/jcem.86.4.7392)

PlouinPFDuclosJMSoppelsaFBoublilGChatellierG. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. Journal of Clinical Endocrinology and Metabolism2001861480–1486. (https://doi.org/10.1210/jcem.86.4.7392))| false

• Search Google Scholar
• Export Citation

11

Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World Journal of Surgery 2002 26 1037–1042. (https://doi.org/10.1007/s00268-002-6667-z)

Prys-RobertsCFarndonJR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World Journal of Surgery2002261037–1042. (https://doi.org/10.1007/s00268-002-6667-z))| false

• Search Google Scholar
• Export Citation

12

Furnica RM, Dusoruth MM, Persu A, Gruson D, Mourad M, Maiter D. Influence of secretory phenotype and preoperative preparation on surgical outcome in pheochromocytoma. Endocrine Connections 2021 10 92–101. (https://doi.org/10.1530/EC-20-0537)

FurnicaRMDusoruthMMPersuAGrusonDMouradMMaiterD. Influence of secretory phenotype and preoperative preparation on surgical outcome in pheochromocytoma. Endocrine Connections20211092–101. (https://doi.org/10.1530/EC-20-0537))| false

• Search Google Scholar
• Export Citation

13

Schimmack S, Kaiser J, Probst P, Kalkum E, Diener MK, Strobel O. Meta-analysis of alpha-blockade versus no blockade before adrenalectomy for phaeochromocytoma. British Journal of Surgery 2020 107 e102–e108. (https://doi.org/10.1002/bjs.11348)

SchimmackSKaiserJProbstPKalkumEDienerMKStrobelO. Meta-analysis of alpha-blockade versus no blockade before adrenalectomy for phaeochromocytoma. British Journal of Surgery2020107e102–e108. (https://doi.org/10.1002/bjs.11348))| false

• Search Google Scholar
• Export Citation

14

Shao Y, Chen R, Shen ZJ, Teng Y, Huang P, Rui WB, Xie X, Zhou WL. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary? Journal of Hypertension 2011 29 2429–2432. (https://doi.org/10.1097/HJH.0b013e32834d24d9)

ShaoYChenRShenZJTengYHuangPRuiWBXieXZhouWL. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?Journal of Hypertension2011292429–2432. (https://doi.org/10.1097/HJH.0b013e32834d24d9))| false

• Search Google Scholar
• Export Citation

15

Jaiswal SK, Memon SS, Lila A, Sarathi V, Goroshi M, Garg R, Barnabas R, Hemantkumar I, Patel RD & Oak S et al.Preoperative amlodipine is efficacious in preventing intraoperative HDI in pheochromocytoma: pilot RCT. Journal of Clinical Endocrinology and Metabolism 2021 106 e2907–e2918. (https://doi.org/10.1210/clinem/dgab231)

JaiswalSKMemonSSLilaASarathiVGoroshiMGargRBarnabasRHemantkumarIPatelRDOakSPreoperative amlodipine is efficacious in preventing intraoperative HDI in pheochromocytoma: pilot RCT. Journal of Clinical Endocrinology and Metabolism2021106 e2907–e2918. (https://doi.org/10.1210/clinem/dgab231))| false

• Search Google Scholar
• Export Citation

16

Berends AMA, Kerstens MN, Lenders JWM, Timmers HJLM. Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma. Journal of Clinical Endocrinology and Metabolism 2020 105 3088–3102. (https://doi.org/10.1210/clinem/dgaa441)

BerendsAMAKerstensMNLendersJWMTimmersHJLM. Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma. Journal of Clinical Endocrinology and Metabolism20201053088–3102. (https://doi.org/10.1210/clinem/dgaa441))| false

• Search Google Scholar
• Export Citation

17

Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative alpha-receptor blockade in phaeochromocytoma surgery: an observational case series. British Journal of Anaesthesia 2017 118 182–189. (https://doi.org/10.1093/bja/aew392)

GroebenHNottebaumBJAlesinaPFTrautANeumannHPWalzMK. Perioperative alpha-receptor blockade in phaeochromocytoma surgery: an observational case series. British Journal of Anaesthesia2017118182–189. (https://doi.org/10.1093/bja/aew392))| false

• Search Google Scholar
• Export Citation

18

Buitenwerf E, Osinga TE, Timmers HJLM, Lenders JWM, Feelders RA, Eekhoff EMW, Haak HR, Corssmit EPM, Bisschop PHLT & Valk GD et al.Efficacy of alpha-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 2020 105 2381–2391. (https://doi.org/10.1210/clinem/dgz188)

BuitenwerfEOsingaTETimmersHJLMLendersJWMFeeldersRAEekhoffEMWHaakHRCorssmitEPMBisschopPHLTValkGDEfficacy of alpha-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism20201052381–2391. (https://doi.org/10.1210/clinem/dgz188))| false

• Search Google Scholar
• Export Citation

19

Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff JB, Tabarin A. Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. Journal of Clinical Endocrinology and Metabolism 2015 100 417–421. (https://doi.org/10.1210/jc.2014-2998)

LafontMFagourCHaissaguerreMDarancetteGWagnerTCorcuffJBTabarinA. Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. Journal of Clinical Endocrinology and Metabolism2015100417–421. (https://doi.org/10.1210/jc.2014-2998))| false

• Search Google Scholar
• Export Citation

20

Wolf KI, Santos JRU, Pacak K. Why take the risk? We only live once: the dangers associated with neglecting a pre-operative alpha adrenoceptor blockade in pheochromocytoma patients. Endocrine Practice 2019 25 106–108. (https://doi.org/10.4158/EP-2018-0455)

WolfKISantosJRUPacakK. Why take the risk? We only live once: the dangers associated with neglecting a pre-operative alpha adrenoceptor blockade in pheochromocytoma patients. Endocrine Practice201925106–108. (https://doi.org/10.4158/EP-2018-0455))| false

• Search Google Scholar
• Export Citation

21

Jasim S, Jimenez C. Metastatic pheochromocytoma and paraganglioma: management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Practice and Research: Clinical Endocrinology and Metabolism 2020 34 101354. (https://doi.org/10.1016/j.beem.2019.101354)

JasimSJimenezC. Metastatic pheochromocytoma and paraganglioma: management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Practice and Research: Clinical Endocrinology and Metabolism202034101354. (https://doi.org/10.1016/j.beem.2019.101354))| false

• Search Google Scholar
• Export Citation

22

Nolting S, Ullrich M, Pietzsch J, Ziegler CG, Eisenhofer G, Grossman A, Pacak K. Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine. Cancers 2019 11 1505. (https://doi.org/10.3390/cancers11101505)

NoltingSUllrichMPietzschJZieglerCGEisenhoferGGrossmanAPacakK. Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine. Cancers2019111505. (https://doi.org/10.3390/cancers11101505))| false

• Search Google Scholar
• Export Citation

23

Scholten A, Cisco RM, Vriens MR, Cohen JK, Mitmaker EJ, Liu C, Tyrrell JB, Shen WT, Duh QY. Pheochromocytoma crisis is not a surgical emergency. Journal of Clinical Endocrinology and Metabolism 2013 98 581–591. (https://doi.org/10.1210/jc.2012-3020)

ScholtenACiscoRMVriensMRCohenJKMitmakerEJLiuCTyrrellJBShenWTDuhQY. Pheochromocytoma crisis is not a surgical emergency. Journal of Clinical Endocrinology and Metabolism201398581–591. (https://doi.org/10.1210/jc.2012-3020))| false

• Search Google Scholar
• Export Citation

24

Giavarini A, Chedid A, Bobrie G, Plouin PF, Hagege A, Amar L. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart 2013 99 1438–1444. (https://doi.org/10.1136/heartjnl-2013-304073)

GiavariniAChedidABobrieGPlouinPFHagegeAAmarL. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart2013991438–1444. (https://doi.org/10.1136/heartjnl-2013-304073))| false

• Search Google Scholar
• Export Citation

25

Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Mortality associated with phaeochromocytoma. Hormone and Metabolic Research 2013 45 154–158. (https://doi.org/10.1055/s-0032-1331217)

PrejbiszALendersJWEisenhoferGJanuszewiczA. Mortality associated with phaeochromocytoma. Hormone and Metabolic Research201345154–158. (https://doi.org/10.1055/s-0032-1331217))| false

• Search Google Scholar
• Export Citation

26

Gagnon N, Mansour S, Bitton Y, Bourdeau I. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocrine Practice 2017 23 1178–1192. (https://doi.org/10.4158/EP171930.OR)

GagnonNMansourSBittonYBourdeauI. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocrine Practice2017231178–1192. (https://doi.org/10.4158/EP171930.OR))| false

• Search Google Scholar
• Export Citation

27

Batisse-Lignier M, Pereira B, Motreff P, Pierrard R, Burnot C, Vorilhon C, Maqdasy S, Roche B, Desbiez F & Clerfond G et al.Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses? A systematic analytical review. Medicine 2015 94 e2198. (https://doi.org/10.1097/MD.0000000000002198)

Batisse-LignierMPereiraBMotreffPPierrardRBurnotCVorilhonCMaqdasySRocheBDesbiezFClerfondGAcute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses? A systematic analytical review. Medicine201594 e2198. (https://doi.org/10.1097/MD.0000000000002198))| false

• Search Google Scholar
• Export Citation

28

Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X & Gimenez-Roqueplo AP et al.Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism 2007 92 3822–3828. (https://doi.org/10.1210/jc.2007-0709)

AmarLBaudinEBurnichonNPeyrardSSilveraSBertheratJBertagnaXSchlumbergerMJeunemaitreXGimenez-RoqueploAPSuccinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism2007923822–3828. (https://doi.org/10.1210/jc.2007-0709))| false

• Search Google Scholar
• Export Citation

29

Buisset C, Guerin C, Cungi PJ, Gardette M, Paladino NC, Taieb D, Cuny T, Castinetti F, Sebag F. Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience. Surgical Endoscopy 2021 35 728–735. (https://doi.org/10.1007/s00464-020-07439-1)

BuissetCGuerinCCungiPJGardetteMPaladinoNCTaiebDCunyTCastinettiFSebagF. Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience. Surgical Endoscopy202135728–735. (https://doi.org/10.1007/s00464-020-07439-1))| false

• Search Google Scholar
• Export Citation

30

Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, Fahey TJ 3rd, Mirallie E, Bresler L, Zarnegar R. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 2014 156 1410–1417; discussion 7–8. (https://doi.org/10.1016/j.surg.2014.08.022)

BrunaudLBoutamiMNguyen-ThiPLFinnertyBGermainAWeryhaGFaheyTJ3rdMirallieEBreslerLZarnegarR. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery20141561410–1417; discussion 7–8. (https://doi.org/10.1016/j.surg.2014.08.022))| false

• Search Google Scholar
• Export Citation

31

Gosse P, Tauzin-Fin P, Sesay MB, Sautereau A, Ballanger P. Preparation for surgery of phaeochromocytoma by blockade of alpha-adrenergic receptors with urapidil: what dose? Journal of Human Hypertension 2009 23 605–609. (https://doi.org/10.1038/jhh.2008.172)

GossePTauzin-FinPSesayMBSautereauABallangerP. Preparation for surgery of phaeochromocytoma by blockade of alpha-adrenergic receptors with urapidil: what dose?Journal of Human Hypertension200923605–609. (https://doi.org/10.1038/jhh.2008.172))| false

• Search Google Scholar
• Export Citation

32

Kong H, Li N, Li XY, Wang DX. The role of pre-operative alpha-blockade in patients with normotensive phaeochromocytoma or paraganglioma: a retrospective cohort study. European Journal of Anaesthesiology 2018 35 898–899. (https://doi.org/10.1097/EJA.0000000000000844)

KongHLiNLiXYWangDX. The role of pre-operative alpha-blockade in patients with normotensive phaeochromocytoma or paraganglioma: a retrospective cohort study. European Journal of Anaesthesiology201835898–899. (https://doi.org/10.1097/EJA.0000000000000844))| false

• Search Google Scholar
• Export Citation

33

Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW, Kazemier G. Risk factors for hemodynamic instability during surgery for pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 2010 95 678–685. (https://doi.org/10.1210/jc.2009-1051)

BruynzeelHFeeldersRAGroenlandTHvan den MeirackerAHvan EijckCHLangeJFde HerderWWKazemierG. Risk factors for hemodynamic instability during surgery for pheochromocytoma. Journal of Clinical Endocrinology and Metabolism201095678–685. (https://doi.org/10.1210/jc.2009-1051))| false

• Search Google Scholar
• Export Citation

34

Haissaguerre M, Courel M, Caron P, Denost S, Dubessy C, Gosse P, Appavoupoulle V, Belleannee G, Jullie ML & Montero-Hadjadje M et al.Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics. Journal of Clinical Endocrinology and Metabolism 2013 98 4346–4354. (https://doi.org/10.1210/jc.2013-1844)

HaissaguerreMCourelMCaronPDenostSDubessyCGossePAppavoupoulleVBelleanneeGJullieMLMontero-HadjadjeMNormotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics. Journal of Clinical Endocrinology and Metabolism2013984346–4354. (https://doi.org/10.1210/jc.2013-1844))| false

• Search Google Scholar
• Export Citation

35

Noshiro T, Shimizu K, Watanabe T, Akama H, Shibukawa S, Miura W, Ito S, Miura Y. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. American Journal of Hypertension 2000 13 35–43. (https://doi.org/10.1016/s0895-7061(9900139-9)

NoshiroTShimizuKWatanabeTAkamaHShibukawaSMiuraWItoSMiuraY. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. American Journal of Hypertension20001335–43. (https://doi.org/10.1016/s0895-7061(9900139-9))| false

• Search Google Scholar
• Export Citation

36

Kopetschke R, Slisko M, Kilisli A, Tuschy U, Wallaschofski H, Fassnacht M, Ventz M, Beuschlein F, Reincke M & Reisch N et al.Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. European Journal of Endocrinology 2009 161 355–361. (https://doi.org/10.1530/EJE-09-0384)

KopetschkeRSliskoMKilisliATuschyUWallaschofskiHFassnachtMVentzMBeuschleinFReinckeMReischNFrequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. European Journal of Endocrinology2009161355–361. (https://doi.org/10.1530/EJE-09-0384))| false

• Search Google Scholar
• Export Citation

37

Challis BG, Casey RT, Simpson HL, Gurnell M. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? Clinical Endocrinology 2017 86 163–167. (https://doi.org/10.1111/cen.13252)

ChallisBGCaseyRTSimpsonHLGurnellM. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma?Clinical Endocrinology201786163–167. (https://doi.org/10.1111/cen.13252))| false

• Search Google Scholar
• Export Citation

38

Namekawa T, Utsumi T, Kawamura K, Kamiya N, Imamoto T, Takiguchi T, Hashimoto N, Tanaka T, Naya Y & Suzuki H et al.Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery 2016 159 763–770. (https://doi.org/10.1016/j.surg.2015.09.016)

NamekawaTUtsumiTKawamuraKKamiyaNImamotoTTakiguchiTHashimotoNTanakaTNayaYSuzukiHClinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery2016159763–770. (https://doi.org/10.1016/j.surg.2015.09.016))| false

• Search Google Scholar
• Export Citation

39

Ma L, Shen L, Zhang X, Huang Y. Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma. Journal of Surgical Oncology 2020. (https://doi.org/10.1002/jso.26079)

MaLShenLZhangXHuangY. Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma. Journal of Surgical Oncology2020. (https://doi.org/10.1002/jso.26079))| false

• Search Google Scholar
• Export Citation

40

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G & Dominiczak A et al.2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension 2018 36 1953–2041. (https://doi.org/10.1097/HJH.0000000000001940)

WilliamsBManciaGSpieringWAgabiti RoseiEAziziMBurnierMClementDLCocaAde SimoneGDominiczakA2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension2018361953–2041. (https://doi.org/10.1097/HJH.0000000000001940))| false

• Search Google Scholar
• Export Citation

41

Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nature Reviews: Cardiology 2013 10 143–155. (https://doi.org/10.1038/nrcardio.2013.1)

ParatiGOchoaJELombardiCBiloG. Assessment and management of blood-pressure variability. Nature Reviews: Cardiology201310143–155. (https://doi.org/10.1038/nrcardio.2013.1))| false

• Search Google Scholar
• Export Citation